DAVID MISIASZEK: Open Payments
NPI 1336847003 · GILMAN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$114 in 4 payments from 2 companies in 2025. Trend: 2023 $46 · 2024 $62 · 2025 $114
Food & beverage: $114
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
Products named: INGREZZA, FANAPT.
Industry payments across CT — which companies pay providers there.
